Blog
Beyond the Pill: Digital Therapeutics & Driving Improved Patient Outcomes
Beyond the Pill: Sanofi’s Approach to Digital Therapeutics & Driving Improved Outcomes for Patients “In the context of the COVID-19 public health emergency, the use of digital health technologies, including software as a medical device or other digital...
Advances in 3D printing of biopharmaceuticals with Merck
Advances in 3D Printing of Biopharmaceuticals Modern technology has enabled the development of novel dosage forms for targeted therapy. However, the fabrication of novel dosage forms at industrial scale is limited and the industry still runs on conventional drug...
Applying Nanoparticle Delivery Approaches for Drug Development
Nanomedicines leading the way Nanotechnology offers multiple benefits in treating chronic diseases by site-specific, and target-oriented delivery of medicines. Nanodelivery systems utilized in drug development are very much still relatively new commercial approach....
New Oral Dose Technology: A Patient-Centric Solution
Improving patient adherence of oral drug products remains a key challenge for drug manufacturers alike. Check out this article and discussion between Pharmaceutical Technology and Adare Pharmaceuticals which discusses a unique approach for industry. Would you like to...
Rapid Development of API Nano-Formulations from Screening to Production
Improving the solubility of poorly soluble APIs remains one of the biggest challenges for pharmaceutical companies. Not to mention the lengthy and costly drug approval processes, generic incursion, rising development costs and the need for novel adherence strategies,...
Enhancing Drug Bioavailability and Solubility
Enhancing Drug Bioavailability and Solubility Approximately 40% of drugs on the market place and a high percentage of APIs in development are poorly soluble. Optimization of drug solubility and BA of therapeutics stands as one of the top challenges faced by the...